VEZT anticorps (AA 480-530)

N° du produit ABIN5690317

Détail du produit anti-VEZT anticorps

Antigène: VEZT (Vezatin, Adherens Junctions Transmembrane Protein (VEZT))

Épitope: AA 480-530

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp VEZT est non-conjugé

Application: ELISA, Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)

Specificité: VEZT antibody is human, mouse and rat reactive. Multiple isoforms are known to exist.

Purification: VEZT antibody is affinity chromatography purified via peptide column.

Immunogène: VEZT antibody was raised against a 17 amino acid peptide near the center of human VEZT.

The immunogen is located within amino acids 480 - 530 of VEZT.

Isotype: IgG

Information d'application

Indications d'application: VEZT antibody can be used for detection of VEZT by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for Immunohistochemistry starting at 5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: VEZT antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: VEZT antibody can be stored at 4°C for three months and -20°C, stable for up to one year.

Détails sur VEZT

Antigène: VEZT (Vezatin, Adherens Junctions Transmembrane Protein (VEZT))

Autre désignation: VEZT (VEZT Produits)

Synonymes: anticorps DKFZp469O2222, anticorps VEZATIN, anticorps 6330418D12, anticorps AI854408, anticorps vezatin, anticorps vezatin, adherens junctions transmembrane protein, anticorps vezatin, adherens junctions transmembrane protein L homeolog, anticorps VEZT, anticorps vezt, anticorps Vezt, anticorps vezt.L

Sujet: Vezatin (VEZT) is a transmembrane protein which localizes to adherens junctions and binds to myosin VIIA and the cadherin-catenins complex (1). Expression of this gene in gastric cancer tissues is decreased due to hypermethylation of the promoter. Expression of this gene may also be inhibited by binding of a specific microRNA to a target sequence in the 3' UTR of the transcripts (2). VEZT has also been shown to be required for morphogenesis of the preimplantation mouse embryo (3).

Poids moléculaire: Predicted: 63, 68, 78, 81, 83, 86 kDa

Observed: 60 kDa

ID gène: 55591

NCBI Accession: NP_060069

UniProt: Q9HBM0